Related Experiment Video
Updated: Feb 8, 2026

Quantifying Replication Stress in Ovarian Cancer Cells Using Single-Stranded DNA Immunofluorescence
Published on: February 10, 2023
Double-negative feedback interaction between DNA methyltransferase 3A and microRNA-145 in the Warburg effect of
Songlin Zhang1, Meili Pei2, Zhen Li2
1Department of Structural Heart Disease, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China.
Abstract:
Ovarian cancer is the most lethal gynecological malignancy because of its poor prognosis. The Warburg effect is one of the key mechanisms mediating cancer progression. Molecules targeting the Warburg effect are therefore of significant therapeutic value for the treatment of cancers. Many microRNAs (miR) are dysregulated in cancers, and aberrant miR expression patterns have been suggested to correlate with the Warburg effect in cancer cells. In our study, we found that miR-145 negatively correlated with DNA methyltransferase (DNMT)3A expression at cellular/histological levels. miR-145 inhibited the Warburg effect by targeting HK2. Luciferase reporter assays confirmed that miR-145-mediated downregulation of DNMT3A occurred through direct targeting of its mRNA 3'-UTRs, whereas methylation-specific PCR (MSP) assays found that knockdown of DNMT3A increased mRNA level of miR-145 and decreased methylation levels of promoter regions in the miR-145 precursor gene, thus suggesting a crucial crosstalk between miR-145 and DNMT3A by a double-negative feedback loop. DNMT3A promoted the Warburg effect through miR-145. Coimmunoprecipitation assays confirmed no direct binding between DNMT3A and HK2. In conclusion, a feedback loop between miR-145 and DNMT3A is a potent signature for the Warburg effect in ovarian cancer, promising a potential target for improved anticancer treatment.
Insights
MicroRNA-145 (miR-145) inhibits the Warburg effect in ovarian cancer by targeting HK2. A feedback loop between miR-145 and DNA methyltransferase 3A (DNMT3A) regulates this process, offering a potential therapeutic target.
Area of Science:
- Oncology
- Molecular Biology
- Biochemistry
Background:
- Ovarian cancer is a lethal gynecological malignancy with a poor prognosis.
- The Warburg effect, a metabolic shift in cancer cells, drives cancer progression.
- MicroRNAs (miRs) are frequently dysregulated in cancers and linked to metabolic alterations.
Purpose of the Study:
- To investigate the role of miR-145 in ovarian cancer.
- To elucidate the relationship between miR-145, DNA methyltransferase 3A (DNMT3A), and the Warburg effect.
- To identify potential therapeutic targets for ovarian cancer.
Main Methods:
- Correlation analysis of miR-145 and DNMT3A expression.
- Luciferase reporter assays to confirm direct targeting of DNMT3A mRNA by miR-145.
- Methylation-specific PCR (MSP) assays to assess promoter methylation of the miR-145 precursor gene.
- Functional assays to evaluate the impact of miR-145 and DNMT3A on the Warburg effect and HK2 expression.
Main Results:
- miR-145 negatively correlated with DNMT3A expression in ovarian cancer.
- miR-145 inhibited the Warburg effect by targeting hexokinase 2 (HK2).
- A double-negative feedback loop exists between miR-145 and DNMT3A, where DNMT3A promotes the Warburg effect via miR-145 regulation.
Conclusions:
- A feedback loop between miR-145 and DNMT3A is a key feature of the Warburg effect in ovarian cancer.
- This regulatory axis represents a promising therapeutic target for improving ovarian cancer treatment.
- Targeting this loop could offer a novel strategy for combating this lethal malignancy.
Related Concept Videos
Positive and Negative Feedback Loops
MicroRNAs
MicroRNAs
Feedback Inhibition
Cell Signaling Feedback Loops
Negative feedback loops
Most signaling systems have negative feedback loops that can perform different functions such as output limiter, and adaptation.
Output limiter
Upon receiving an input signal, the cellular response rapidly increases until a threshold is reached. Beyond this threshold, a negative feedback loop...
Fixing Double-strand Breaks

